Gascoyne RD - Search Results

1

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA. Evens AM, et al. Among authors: gascoyne rd. Am J Hematol. 2015 Sep;90(9):778-83. doi: 10.1002/ajh.24082. Am J Hematol. 2015. PMID: 26044261 Free article.

2

Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.

Lee AY, Connors JM, Klimo P, O'Reilly SE, Gascoyne RD. Lee AY, et al. Among authors: gascoyne rd. J Clin Oncol. 1997 May;15(5):1745-53. doi: 10.1200/JCO.1997.15.5.1745. J Clin Oncol. 1997. PMID: 9164181

3

Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma.

Gascoyne RD. Gascoyne RD. Hematol Oncol Clin North Am. 1997 Oct;11(5):847-62. doi: 10.1016/s0889-8588(05)70466-4. Hematol Oncol Clin North Am. 1997. PMID: 9336718 Review.

4

Bone marrow involvement in T-cell-rich B-cell lymphoma.

Skinnider BF, Connors JM, Gascoyne RD. Skinnider BF, et al. Among authors: gascoyne rd. Am J Clin Pathol. 1997 Nov;108(5):570-8. doi: 10.1093/ajcp/108.5.570. Am J Clin Pathol. 1997. PMID: 9353097

5

Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma.

Gascoyne RD, Krajewska M, Krajewski S, Connors JM, Reed JC. Gascoyne RD, et al. Blood. 1997 Oct 15;90(8):3173-8. Blood. 1997. PMID: 9376600 Free article.

6

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.

Hoskins PJ, Le N, Gascoyne RD, Klasa R, Shenkier T, O'Reilly S, Connors JM. Hoskins PJ, et al. Among authors: gascoyne rd. Ann Oncol. 1997 Nov;8(11):1125-32. doi: 10.1023/a:1008263602334. Ann Oncol. 1997. PMID: 9426332 Free article.

7

Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation.

Macpherson N, Lesack D, Klasa R, Horsman D, Connors JM, Barnett M, Gascoyne RD. Macpherson N, et al. Among authors: gascoyne rd. J Clin Oncol. 1999 May;17(5):1558-67. doi: 10.1200/JCO.1999.17.5.1558. J Clin Oncol. 1999. PMID: 10334544

8

Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, Morris SW, Connors JM, Vose JM, Viswanatha DS, Coldman A, Weisenburger DD. Gascoyne RD, et al. Blood. 1999 Jun 1;93(11):3913-21. Blood. 1999. PMID: 10339500 Free article.

9

Anaplastic large cell lymphoma: a clinicopathologic analysis.

Skinnider BF, Connors JM, Sutcliffe SB, Gascoyne RD. Skinnider BF, et al. Among authors: gascoyne rd. Hematol Oncol. 1999 Dec;17(4):137-48. doi: 10.1002/(sici)1099-1069(199912)17:4<137::aid-hon642>3.0.co;2-v. Hematol Oncol. 1999. PMID: 10725869 Review.

10

Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma.

Weisenburger DD, Gascoyne RD, Bierman PJ, Shenkier T, Horsman DE, Lynch JC, Chan WC, Greiner TC, Connors JM, Vose JM, Armitage JO, Sanger WG. Weisenburger DD, et al. Among authors: gascoyne rd. Leuk Lymphoma. 2000 Feb;36(5-6):513-23. doi: 10.3109/10428190009148399. Leuk Lymphoma. 2000. PMID: 10784396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters